Home › NDC Lookup › RxCUI directory › RxCUI 197685

Etodolac 300 MG Oral Capsule — RxCUI 197685

RxNorm drug concept · Semantic clinical drug
RxCUI 197685 Semantic clinical drug · SCD ● Current RxNorm concept 18 FDA products 22 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI197685
Official nameEtodolac 300 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped18
Package NDCs mapped22
Reported Medicaid activity (SDUD)9,860 prescriptions · 30 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Etodolac: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Etodolac is used to treat the pain and inflammation of osteoarthritis and rheumatoid arthritis. The capsule and tablet forms are also approved for short-term acute pain. The extend...
  • You can take etodolac with or without food — food doesn't significantly change the total amount your body absorbs. That said, if etodolac irritates your stomach, taking it with foo...
  • The most common side effects are stomach-related — nausea, heartburn, diarrhea, or abdominal discomfort — along with dizziness, headache, and ringing in the ears. Most are mild. Th...
  • What side effects should I actually watch out for?
📖 Read our full Etodolac guide →

🕸️ Concept Web — How Etodolac 300 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Etodolac 300 MG Oral Capsule RxCUI 197685

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Etodolac 24605
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Etodolac Oral Capsule 372125
    • Etodolac Oral Product 1157924
    • Etodolac Pill 1157925
    • Oral Capsule 316965
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Etodolac 300 MG 315907

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Etodolac 300 MG SCDC · 315907
  • Etodolac Oral Capsule SCDF · 372125
  • Etodolac Oral Product SCDG · 1157924
  • Etodolac Pill SCDG · 1157925

📦 FDA Products & Package NDCs

18 products · 22 package NDCs
22 package NDCs map to RxCUI 197685 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50090-2132-01 21 CAPSULE in 1 BOTTLE (50090-2132-1) Etodolac A-S Medication Solutions 2015-10-15
51655-0166-52 30 CAPSULE in 1 BOTTLE, DISPENSING (51655-166-52) Etodolac Northwind Health Company, LLC 2014-11-13
51672-4016-01 100 CAPSULE in 1 BOTTLE (51672-4016-1) Etodolac Taro Pharmaceuticals U.S.A., Inc. 1998-04-30
51672-4017-01 100 CAPSULE in 1 BOTTLE (51672-4017-1) Etodolac Taro Pharmaceuticals U.S.A., Inc. 1998-04-30
51672-4018-01 100 TABLET, FILM COATED in 1 BOTTLE (51672-4018-1) Etodolac Taro Pharmaceuticals U.S.A., Inc. 1998-03-11
51672-4036-01 100 TABLET, FILM COATED in 1 BOTTLE (51672-4036-1) Etodolac Taro Pharmaceuticals U.S.A., Inc. 2000-04-25
60429-0243-01 100 CAPSULE in 1 BOTTLE (60429-243-01) Etodolac Golden State Medical Supply, Inc. 2011-07-18
60429-0244-01 100 CAPSULE in 1 BOTTLE (60429-244-01) Etodolac Golden State Medical Supply, Inc. 2011-07-18
60429-0311-01 100 TABLET, FILM COATED in 1 BOTTLE (60429-311-01) Etodolac Golden State Medical Supply, Inc. 2011-07-18
60429-0312-01 100 TABLET, FILM COATED in 1 BOTTLE (60429-312-01) Etodolac Golden State Medical Supply, Inc. 2011-07-18
60505-0039-01 100 CAPSULE in 1 BOTTLE (60505-0039-1) Etodolac Apotex Corp. 2003-05-01
60505-0040-01 100 CAPSULE in 1 BOTTLE (60505-0040-1) Etodolac Apotex Corp. 2003-05-01
62559-0250-01 100 CAPSULE in 1 BOTTLE (62559-250-01) Etodolac ANI Pharmaceuticals, Inc. 2015-03-09
62559-0251-01 100 CAPSULE in 1 BOTTLE (62559-251-01) Etodolac ANI Pharmaceuticals, Inc. 2015-02-01
63629-1936-01 100 CAPSULE in 1 BOTTLE (63629-1936-1) Etodolac Bryant Ranch Prepack 2021-06-29
72162-1757-01 100 CAPSULE in 1 BOTTLE (72162-1757-1) Etodolac Bryant Ranch Prepack 2026-03-25
83980-0031-01 100 CAPSULE in 1 BOTTLE (83980-031-01) etodolac Ipca Laboratories Limited 2026-02-06
83980-0031-05 500 CAPSULE in 1 BOTTLE (83980-031-05) etodolac Ipca Laboratories Limited 2026-02-06
83980-0031-13 30 CAPSULE in 1 BOTTLE (83980-031-13) etodolac Ipca Laboratories Limited 2026-02-06
83980-0032-01 100 CAPSULE in 1 BOTTLE (83980-032-01) etodolac Ipca Laboratories Limited 2026-02-06
83980-0032-05 500 CAPSULE in 1 BOTTLE (83980-032-05) etodolac Ipca Laboratories Limited 2026-02-06
83980-0032-13 30 CAPSULE in 1 BOTTLE (83980-032-13) etodolac Ipca Laboratories Limited 2026-02-06
Observed labelers: Ipca Laboratories Limited (6) · Golden State Medical Supply, Inc. (4) · Taro Pharmaceuticals U.S.A., Inc. (4) · ANI Pharmaceuticals, Inc. (2) · Apotex Corp. (2) · Bryant Ranch Prepack (2) · +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.